What it sells
Using the immune system to cure disease
Business model breakdown
Workflow: what inputs become what output?
Test candidate therapies on population-scale human organoid data instead of animal models to choose targets and predict failure earlier.
Economics: what it saves and how it charges
UnverifiedPartnership / discovery deals plus proprietary data compounding; terms not stated.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Summer 2021 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.